Finsbury Worldwide Pharm Tst PLC
27 February 2002
STOCK EXCHANGE ANNOUNCEMENT
FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
27 February 2002
Application has been made to the London Stock Exchange and the UK Listing
Authority for 50,000 Ordinary Shares of 25p each fully paid to be admitted to
trading and to the Official List. The new shares will rank pari passu with the
existing Ordinary Shares.
These shares were issued for cash on 22 February 2002 at a price of 562.0p per
share. The net asset value per Ordinary Share at the close of business on 21
February 2002 was 547.2p. Following the issue there are 39,190,000 Ordinary
Shares in issue.
Enquiries:
Faith Pengelly
Close Finsbury Asset Management Limited
Tel: 020 7426 6229
Nathan Brown
HSBC Investment Bank plc
Tel: 020 7336 4331
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.